Yutaka Kawakami
Affiliations: | Keio University, Minato-ku, Tōkyō-to, Japan |
Google:
"Yutaka Kawakami"Mean distance: 16.96 (cluster 17)
Children
Sign in to add traineeYohei Ohashi | research assistant | 2000-2004 | Keio University |
Yukihiko Iizuka | grad student | 1999-2004 | Keio University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ohta S, Misawa A, Kyi-Tha-Thu C, et al. (2023) Melanoma antigens recognized by T cells and their use for immunotherapy. Experimental Dermatology |
Morimoto Y, Tokumitsu A, Sone T, et al. (2022) TPT1 Supports Proliferation of Neural Stem/Progenitor Cells and Brain Tumor Initiating Cells Regulated by Macrophage Migration Inhibitory Factor (MIF). Neurochemical Research |
Wang B, Xu Z, Sunthamala N, et al. (2022) Combinatorial sympathetic and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockades inhibit the murine melanoma growth by targeting infiltrating T cells. Translational Cancer Research. 10: 899-913 |
Fukuda K, Okamura K, Riding RL, et al. (2021) AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. The Journal of Experimental Medicine. 218 |
Hirai I, Funakoshi T, Kamijuku H, et al. (2021) Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors. Cancer Science |
Kinoshita T, Sayem MA, Yaguchi T, et al. (2021) Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors. Cancer Science |
Yamada K, Hazama S, Suzuki N, et al. (2021) Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancer. Oncology Letters. 21: 10 |
Hayakawa T, Yaguchi T, Kawakami Y. (2020) Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3. Cancer Science |
Sugihara E, Hashimoto N, Osuka S, et al. (2020) The inhibitor of apoptosis protein Livin confers resistance to Fas-mediated immune cytotoxicity in refractory lymphoma. Cancer Research |
Ohno A, Iwata T, Katoh Y, et al. (2020) Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy. Gynecologic Oncology |